Association of HbA1c with Diabetic Retinopathy in Diabetic Patients
DOI:
https://doi.org/10.21649/akemu.v31i1.5631Keywords:
Diabetic retinopathy,, diabetes, HbA1CAbstract
Background: Retinopathy due to diabetes is increasing in patients due to increase prevalence of diabetes.
Objective : We tried to find if there is any association of HbA1c with Diabetic Retinopathy in diabetic patients of Kharian.
Methods: This study was conducted in OPD medical department of THQ hospital Kharian after getting approval letter (CKMC/IERB/AC-00104) from Institutional Ethical Review Board of CMH Kharian Medical College. Consent was taken from 150 randomly selected diabetic patients. It was a cross-sectional study from 10 Oct 2023 to 10 Jan 2024. History was taken from the patient to know their parameters of age, gender, duration of diabetes. Indirect fundoscopy of all patients was performed to assess the status of retinopathy. We checked HbA1C, random blood glucose levels of patients.
Results: All 150 diabetic patients were examined for diabetic retinopathy. Diabetic retinopathy was prevalent among 50 % of the participants. 75 patients had diabetic retinopathy. Significant association was found between diabetic retinopathy and HbA1c levels of HbA1c (p = 0.001). Duration of diabetes mellitus and family history of diabetes was also significantly associated with diabetic retinopathy (p = 0.001).
Conclusion: One-half of the diabetic patients in our study had retinopathy. Levels of HbA1c and duration of diabetes mellitus are demonstrated as undeniable risk factors for Diabetic Retinopathy and can be used for screening to prevent blindness due to diabetic retinopathy.
References
1. Christ-Crain M, Winzeler B, Refardt J. Diagnosis and management of diabetes insipidus for the internist: an update.J intern Med . 2021;290(1):73-87.
2. Tomkins M, Lawless S, Martin-Grace J, Sherlock M, Thompson CJ. Diagnosis and Management of Central Diabetes Insipidus in Adults. J Clin Endocrinol Metab. 2022;107(10):2701-15. doi:10.1210/clinem/dgac381
3. Kolarić V, Svirčević V, Bijuk R, Zupančič V. Chronic Complications of diabetes and quality of Life. Acta Clin Croat. 2022;61(3):520-27. doi:10.20471/acc.2022.61.03.18
4. Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-25. doi: 10.1111/jdi.13480. Epub 2021 Jan 14. PMID: 33316144; PMCID: PMC8354492.
5. Akhtar S, Shah SW, Javed S, Alina A. Prevalence of diabetes and prediabetes in district Swat Pakistan. J Pak Med Assoc. 2021;71(1(B)):243-46. doi:10.47391/JPMA.548
6. Fung TH, Patel B, Wilmot EG, Amoaku WM. Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond). 2022;22(2):112-16. doi:10.7861/clinmed.2021-0792
7. Li Y, Mitchell W, Elze T, Zebardast N. Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.Curr Diab Rep. 2021;21(10):38.
8. Azad R, Sinha S, Nishant P. Asymmetric diabetic retinopathy. Indian J Ophthalmol. 2021;69(11):3026-34. doi:10.4103/ijo.IJO_1525_21
9. Chaudhary S, Zaveri J, Becker N. Proliferative diabetic retinopathy (PDR). Dis Mon. 2021;67(5):101140. doi:10.1016/j.disamonth.2021.101140
10. Augustine J, Troendle EP, Barabas P, McAleese C A, Friedel T,Stitt AW et al. The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy. Front Endocrinol (Lausanne). 2021;11:621938. doi:10.3389/fendo.2020.62193
11. Masroor M, Haque Z. HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters. J Clin Transl Hepatol. 2021;9(1):15-21. doi:10.14218/JCTH.2019.00046
12. Lind M, Imberg H, Coleman RL, Nerman O, Holman RR. Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 2021; 7(10):2231–37. doi:10.2337/dc20-2439
13. Goldney J, Sargeant JA, Davies MJ. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy. Diabetologia. 2023;66(10):1832-45. doi:10.1007/s00125-023-05988-3
14. Onoe H, Tanaka K, Tsuchiya N, Miyata K, Kitaoka M, Nakayama M et al. Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusion. PLoS One. 2023;18(12):e0291456.
15. Zhou J, Zhu L, Li Y. Association between the triglyceride glucose index and diabetic retinopathy in type 2 diabetes: a meta-analysis. Front Endocrinol (Lausanne). 2023;14:1302127. doi:10.3389/fendo.2023.1302127
16. Almutairi NM, Alahmadi S, Alharbi M, Gotah S, Alharbi M. The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy. Cureus. 2021;13(1):e12520. doi:10.7759/cureus.12520
17. Perais J, Agarwal R, Evans JR, Loveman E, Colquitt JL , Owens D et al. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. CochraneDatabaseSystRev.2023;2(2):CD013775. doi:10.1002/14651858.CD013775.
18. Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY et al. Prevalence of Diabetic Retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747-54. doi:10.1001/jamaophthalmol.2023.2289
19. Liu X, Chang Y, Li Y, Liu Y, Chen N, Cui J. Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008. Am J Ophthalmol. 2024;266:56-67. doi:10.1016/j.ajo.2024.05.019
20. Hou X, Wang L, Zhu D, Lixin G, Weng J ,Zhang M et al. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China. Nat Commun. 2023;14(1):4296.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk